Diana, Princess of Wales Hospital is a public hospital in Grimsby, Lincolnshire, England. It is managed by the Northern Lincolnshire and Goole Hospitals NHS Foundation Trust.

During the past decade, Diana Princess of Wales Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diana Princess of Wales Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "University of Leeds" with 3 trials sponsored, "Medical Research Council" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diana Princess of Wales Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Diana Princess of Wales Hospital" are "Breast Cancer" (7 trials), "Metastatic Cancer" (4 trials), "Breast Neoplasms" (2 trials), "Hypercalcemia of Malignancy" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Diana Princess of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Diana Princess of Wales Hospital" are "Drug" (27 trials), "Procedure" (7 trials), "Biological" (4 trials), "Radiation" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "Atezolizumab" (4 trials), "adjuvant therapy" (4 trials), "Docetaxel" (3 trials) and "capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Diana Princess of Wales Hospital" are 24 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Diana Princess of Wales Hospital". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Diana Princess of Wales Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Diana Princess of Wales Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".